The Effects of Regular Inhaled Formoterol, Budesonide, and Placebo on Mucosal Inflammation and Clinical Indices in Mild Asthma
- 1 January 1999
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 159 (1) , 79-86
Abstract
The present study was designed to observe the effects of 8 wk of treatment with formoterol (Foradil) 24 μ g, budesonide 400 μ g, and matched placebo inhaled twice a day on inflammatory indices in the bronchial mucosa of 64 patients with mild atopic asthma. Biopsies were obtained at the start and 1 wk before stopping a 9-wk period of treatment, and inflammatory cell numbers were assessed in the submucosa and epithelium by immunohistochemistry. Regular formoterol significantly reduced the number of submucosal mast cells, with a similar trend for eosinophils but not activated T cells. A subgroup analysis conducted in biopsies with ≥ 10 eosinophils per mm2 revealed a significant reduction in eosinophil numbers when compared with both pretreatment baseline (p < 0.01) and changes after placebo (p < 0.01). Parallel, but less pronounced, effects were observed on mast cell but not on CD25+ T cell numbers. There was no effect of any of the three treatments on BAL levels of mast cell or eosinophil mediators. We conclude that regular treatment with inhaled formoterol reduces rather than increases inflammatory cells in the mucosa of asthmatic patients. It is possible that these cellular effects of formoterol may contribute to the therapeutic efficacy of this drug when used regularly in the treatmentKeywords
This publication has 26 references indexed in Scilit:
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- Mechanisms of human eosinophil survival and apoptosisClinical & Experimental Allergy, 1997
- Current best practice for nebuliser treatment. British Thoracic Society Nebulizer Project Groupx [published erratum appears in Thorax 1997 Sep;52(9):838]Thorax, 1997
- Comparison of Regularly Scheduled with As-Needed Use of Albuterol in Mild AsthmaNew England Journal of Medicine, 1996
- Effects of theophylline on inflammatory cells and cytokines in asthmatic subjects: a placebo-controlled parallel group studyEuropean Respiratory Journal, 1996
- Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroidThe Lancet, 1994
- Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthmaJournal of Allergy and Clinical Immunology, 1993
- Immunohistochemistry on Resin Sections: A Comparison of Resin Embedding Techniques for Small Mucosal BiopsiesBiotechnic & Histochemistry, 1993
- A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trialJournal of Allergy and Clinical Immunology, 1992
- Protection against allergen-induced asthma by salmeterolThe Lancet, 1990